Friday, 18 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14435
Articles
Company
Drug
Eli Lilly’s Donanemab Set to Gain Breakthrough Therapy Designation in China
January 25, 2025
Company
Deals
Changzhou Sifary Medtech Secures Series B Funding for Global Expansion
January 25, 2025
Company
Drug
Suzhou Thery’s Generic Nilotinib Approved by China’s NMPA
January 28, 2025
Company
Drug
Zhifei Biological Products’ BCG Vaccine Filing Accepted by China’s NMPA
January 25, 2025
Company
Drug
Yantai Dongcheng Pharma Gets FDA Go-Ahead for 177Lu-LNC1004 Clinical Trial
January 25, 2025
Company
Deals
VivaVision Biotech Partners with Everads Therapy for Retinal Disease Therapies
January 25, 2025
Company
Deals
Shenzhen-Based Rhegen Bio Raises RMB 100 Million in Pre-Series B Round
January 25, 2025
Company
Drug
Hainan Poly Pharm’s Generic Ganciclovir Approved in Denmark
January 25, 2025
Company
Drug
Jacobio Pharma Doses First Patient in US Phase I/IIa Study for JAB-2485
January 25, 2025
Company
Deals
VACSERA in Talks with Sinovac to Establish Integrated Vaccine Plant
January 25, 2025
Company
Drug
Eisai CEO Outlines Ambitions for Alzheimer’s Drug Leqembi After FDA Approval
January 25, 2025
Company
Drug
Dizal’s Sunvozertinib and Golidocitinib Combo Gets NMPA Approval for Phase II Study
January 26, 2025
1
2
…
1,054
1,055
1,056
1,057
1,058
…
1,202
1,203
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?